Your browser doesn't support javascript.
ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants.
Ou, Jianxia; Zhang, Yanan; Wang, Yongmei; Zhang, Zherui; Wei, Hongping; Yu, Junping; Wang, Qi; Wang, Guifeng; Zhang, Bo; Wang, Chunhe.
  • Ou J; Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Shanghai, China.
  • Zhang Y; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wang Y; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang Z; University of Chinese Academy of Sciences, Beijing, China.
  • Wei H; Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Shanghai, China.
  • Yu J; University of Chinese Academy of Sciences, Beijing, China.
  • Wang Q; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Wang G; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang B; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Wang C; University of Chinese Academy of Sciences, Beijing, China.
Signal Transduct Target Ther ; 7(1): 43, 2022 02 09.
Article in English | MEDLINE | ID: covidwho-1683983

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Antibodies, Neutralizing / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Drug Treatment / Antibodies, Viral Topics: Variants Limits: Animals / Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-00913-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Antibodies, Neutralizing / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Drug Treatment / Antibodies, Viral Topics: Variants Limits: Animals / Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-00913-3